跳至主要内容
临床试验/CTRI/2020/02/023290
CTRI/2020/02/023290尚未招募1/2 期

Randomized, Controlled, Clinical Study to evaluate the efficacy of Pratham Trifala Rasayana as adjuvant therapy in Mutraghata with special reference to Chronic Renal Failure.

Sanjivani Jadhao Rathod1 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2020年2月17日最近更新:

试验速览

阶段
1/2 期
状态
尚未招募
发起方
入组人数
122
试验地点
1
主要终点
Increase in appetite

研究概览

简要总结

This study drug along with standerd treatment for chronic renal failure may improve renal function in cases of chronic renal failure as compaired to baseline and may improve renal function renal conditionor slow down the progration of disease and it increases Hb% dhatuwardhana takes place hence general condition is improved.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
25.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Pre diagnosed patients of CKD of Stage I to III
  • Both sexes male and female.
  • Willing to Consent & Participate.
  • Age 25 to 65 years.
  • Patients having classical sign and symptoms of CKD such as Shotha (oedema), fatigability (weakness), Swaskashtata (Dyspnoea), anannabhilasha (anorexia), Panduta (less haemoglobin) etc.

排除标准

  • Acute Renal Failure
  • Uremic Coma
  • Known Patients of Renal Artery Stenosis
  • Age < 25 and > 65 years.
  • Patients of Carcinoma
  • Participate in other clinical trial within 30 days prior to this trial.
  • History of previous kidney transplant.
  • HIV and VDRL infected patients will be excluded.

结局指标

主要结局

Increase in appetite

时间窗: 90 days

Improvement in urinary output

时间窗: 90 days

Improvement in fatigue

时间窗: 90 days

Reduction in edema

时间窗: 90 days

次要结局

  • Improvement in signs and symptoms of CKD(90 days)

研究者

发起方
Sanjivani Jadhao Rathod
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验

To evaluate the efficacy of pratham triphala rasayan... | 临床试验